{"log_id": 1024529435873691913, "direction": 0, "words_result_num": 45, "words_result": [{"probability": {"variance": 1.9e-05, "average": 0.997727, "min": 0.978615}, "location": {"width": 993, "top": 103, "height": 53, "left": 81}, "words": "【禁忌】下列情况禁用:①对本品有过敏史或皮试阳性者;②有胰腺炎病史或现患胰腺炎者;③"}, {"probability": {"variance": 8e-06, "average": 0.998522, "min": 0.986348}, "location": {"width": 1000, "top": 136, "height": 52, "left": 76}, "words": "现患水痘、广泛带状疱疹等严重感染者。④由于不能排除本品有潜在的致畸胎、致突变和致继发性"}, {"probability": {"variance": 0, "average": 0.99943, "min": 0.99815}, "location": {"width": 426, "top": 182, "height": 40, "left": 75}, "words": "癌的作用,妊娠三个月内的孕妇避免使用"}, {"probability": {"variance": 0.007486, "average": 0.980993, "min": 0.531968}, "location": {"width": 617, "top": 207, "height": 50, "left": 81}, "words": "【注意事项】(1)来源于埃希大肠杆菌与来源于欧文菌族Er"}, {"probability": {"variance": 1e-06, "average": 0.999163, "min": 0.997798}, "location": {"width": 230, "top": 204, "height": 30, "left": 846}, "words": "a的门冬酰胺酶间偶有"}, {"probability": {"variance": 0, "average": 0.999711, "min": 0.998956}, "location": {"width": 143, "top": 256, "height": 32, "left": 78}, "words": "交叉敏感反应"}, {"probability": {"variance": 3e-06, "average": 0.999104, "min": 0.989035}, "location": {"width": 980, "top": 268, "height": 53, "left": 97}, "words": "2)对诊断的干扰:①甲状腺功能试验,首次注射本品的2日内,患者血清中的甲状腺结合蛋"}, {"probability": {"variance": 0.000814, "average": 0.994032, "min": 0.812494}, "location": {"width": 998, "top": 300, "height": 56, "left": 78}, "words": "白浓度下降,直至最后一次注射本品后的4周内,浓度才恢复正常;②由于门冬酰胺的分解,血"}, {"probability": {"variance": 6.8e-05, "average": 0.997342, "min": 0.949442}, "location": {"width": 1002, "top": 334, "height": 54, "left": 78}, "words": "氨及尿素氮浓度可能增加;③血糖、血尿酸及尿尿酸可能增加;④在治疗的最初3周内,部分凝"}, {"probability": {"variance": 0.000683, "average": 0.994989, "min": 0.828111}, "location": {"width": 1001, "top": 369, "height": 57, "left": 77}, "words": "血活酶时间、凝血酶原时间、凝血酶时间等可能延长,血小板计数可能增加;⑤由于本品抑制血"}, {"probability": {"variance": 2e-06, "average": 0.998944, "min": 0.993021}, "location": {"width": 989, "top": 399, "height": 55, "left": 80}, "words": "浆蛋白的合成,患者的血浆纤维蛋白原、抗凝血酶、纤维蛋白溶酶原、血清白蛋白的浓度可能降低"}, {"probability": {"variance": 5e-06, "average": 0.998769, "min": 0.988174}, "location": {"width": 717, "top": 439, "height": 47, "left": 82}, "words": "⑥如有肝功能异常提示为肝毒性、肝损害的征兆;⑦血清钙可能降低"}, {"probability": {"variance": 5e-06, "average": 0.99852, "min": 0.987742}, "location": {"width": 987, "top": 466, "height": 52, "left": 92}, "words": "(3)下列情况慎用:①糖尿病;②痛风或肾尿酸盐结石史;③肝功能不全、感染等;④以往"}, {"probability": {"variance": 8e-06, "average": 0.998378, "min": 0.989847}, "location": {"width": 305, "top": 517, "height": 32, "left": 84}, "words": "曾用细胞毒或放射治疗的患者"}, {"probability": {"variance": 2.7e-05, "average": 0.998507, "min": 0.965659}, "location": {"width": 983, "top": 530, "height": 55, "left": 95}, "words": "(4)在治疗开始前及治疗期间随访下列检测:周围血象、血浆凝血因子、血糖、血清淀粉酶、血"}, {"probability": {"variance": 2.2e-05, "average": 0.998567, "min": 0.973796}, "location": {"width": 729, "top": 568, "height": 50, "left": 83}, "words": "尿酸、肝功能、肾功能、骨髓涂片分类、血清钙、中枢神经系统功能等"}, {"probability": {"variance": 4e-06, "average": 0.998613, "min": 0.99068}, "location": {"width": 967, "top": 594, "height": 57, "left": 91}, "words": "(5)由于本品能进一步抑制患者的免疫机制,并增加所接种病毒的增殖能力、毒性及不良反应"}, {"probability": {"variance": 9.6e-05, "average": 0.997139, "min": 0.939046}, "location": {"width": 1003, "top": 628, "height": 54, "left": 85}, "words": "故在接受本品治疗的3个月内不宜接受活病毒疫苗接种,另与患者密切接触者的口服脊髓灰质炎疫"}, {"probability": {"variance": 2e-06, "average": 0.998646, "min": 0.995538}, "location": {"width": 166, "top": 684, "height": 30, "left": 85}, "words": "苗时间亦应推迟"}, {"probability": {"variance": 5e-06, "average": 0.998733, "min": 0.988404}, "location": {"width": 976, "top": 693, "height": 55, "left": 110}, "words": "6)给药说明:①患者必须住院,在对肿瘤化疗有经验的医生指导下治疗,每次注射前须备有抗"}, {"probability": {"variance": 1.4e-05, "average": 0.998168, "min": 0.984536}, "location": {"width": 992, "top": 726, "height": 55, "left": 85}, "words": "过敏反应的药物(包括肾上腺素、抗组胺药物、静脉用的类固醇药物如地塞米松等),及抢救器械"}, {"probability": {"variance": 2.1e-05, "average": 0.997735, "min": 0.977757}, "location": {"width": 1002, "top": 759, "height": 55, "left": 88}, "words": "②凡首次采用本品或已用过本品但已停药一周或一周以上的患者,在注射本品前须做皮试。皮试的"}, {"probability": {"variance": 0.00115, "average": 0.988749, "min": 0.844943}, "location": {"width": 1001, "top": 790, "height": 56, "left": 87}, "words": "药液可按下列方法制备:加5ml的灭菌注射用水或氯化钠注射液入小瓶内摇动,使小瓶内10000单"}, {"probability": {"variance": 0.008475, "average": 0.97316, "min": 0.579961}, "location": {"width": 971, "top": 825, "height": 54, "left": 85}, "words": "位的门冬酰胺酶溶解,抽取0.1m1(每1ml含2000单位),注入另一含9.9ml稀释液的小瓶内"}, {"probability": {"variance": 0.004546, "average": 0.983795, "min": 0.625632}, "location": {"width": 993, "top": 856, "height": 55, "left": 89}, "words": "制成浓度约为1ml含20单位的皮试药液。用0.1ml皮试液(约为2.0单位)做皮试,至少观察1"}, {"probability": {"variance": 3e-06, "average": 0.998893, "min": 0.991347}, "location": {"width": 996, "top": 888, "height": 56, "left": 91}, "words": "小时,如有红斑或风团极为皮试阳性反应。患者必须皮试阴性才能接受本品治疗。③应从静脉大"}, {"probability": {"variance": 7e-06, "average": 0.99856, "min": 0.986215}, "location": {"width": 987, "top": 921, "height": 55, "left": 90}, "words": "量补充液体,碱化尿液,口服别嘌醇,以预防白血病或淋巴瘤患者发生高尿酸血症和尿酸性肾病"}, {"probability": {"variance": 1.6e-05, "average": 0.998417, "min": 0.975462}, "location": {"width": 996, "top": 953, "height": 56, "left": 93}, "words": "④由于使用本品后会很快产生抗药性,故本品不宜用作急淋等患者缓解后的维持治疗方案。⑤本"}, {"probability": {"variance": 0.002326, "average": 0.986968, "min": 0.698537}, "location": {"width": 1006, "top": 988, "height": 55, "left": 89}, "words": "品可经静滴、静注、或肌注给药。静注前必须用灭菌注射用水或氯化钠注射液加以稀释,每1000"}, {"probability": {"variance": 0.004793, "average": 0.986606, "min": 0.536373}, "location": {"width": 990, "top": 1019, "height": 55, "left": 90}, "words": "单位的小瓶稀释液量为5m1。静注给药时,本品应经正在输注的氯化钠或葡萄糖注射液的侧管注入"}, {"probability": {"variance": 0.003437, "average": 0.989712, "min": 0.61444}, "location": {"width": 970, "top": 1052, "height": 54, "left": 92}, "words": "静注的时间不得短于半小时。静滴法给药,本品要先用等渗液如氯化钠或5%葡萄糖注射液稀释"}, {"probability": {"variance": 0.001613, "average": 0.992759, "min": 0.726775}, "location": {"width": 1001, "top": 1085, "height": 55, "left": 93}, "words": "然后加入氯化钠或5%葡萄糖注射液中滴入。⑥肌内注射,先要在含本品10000单位的小瓶内加入"}, {"probability": {"variance": 0.00177, "average": 0.989846, "min": 0.736547}, "location": {"width": 997, "top": 1116, "height": 56, "left": 94}, "words": "2ml氯化钠注射液加以稀释,每一个肌注部位每一次的肌注量不应超过2ml。不论经静脉或肌内注"}, {"probability": {"variance": 2e-06, "average": 0.999034, "min": 0.995004}, "location": {"width": 660, "top": 1157, "height": 47, "left": 95}, "words": "射,稀释液一定要成澄清才能使用,且要在稀释后8小时内应用"}, {"probability": {"variance": 0.00029, "average": 0.995929, "min": 0.887218}, "location": {"width": 996, "top": 1180, "height": 56, "left": 102}, "words": "【孕妇及哺乳期妇女用药】由于不能排除本品有潜在的致畸胎、致突变和致继发性癌的作用,妊娠"}, {"probability": {"variance": 6.1e-05, "average": 0.998051, "min": 0.949045}, "location": {"width": 990, "top": 1214, "height": 54, "left": 94}, "words": "3个月内的孕妇避免使用。由于考虑到本品对婴儿的危害,在哺乳期间接受治疗的乳母应停止哺乳"}, {"probability": {"variance": 3e-06, "average": 0.998526, "min": 0.994362}, "location": {"width": 230, "top": 1268, "height": 31, "left": 104}, "words": "【儿童用药】尚不明确"}, {"probability": {"variance": 2e-06, "average": 0.998771, "min": 0.996072}, "location": {"width": 231, "top": 1301, "height": 29, "left": 104}, "words": "【老年用药】尚不明确"}, {"probability": {"variance": 5e-06, "average": 0.998745, "min": 0.986356}, "location": {"width": 983, "top": 1311, "height": 56, "left": 105}, "words": "【药物相互作用】(1)泼尼松或促皮质素或长春新碱与本品同用时,会增强本品的致高血糖作用"}, {"probability": {"variance": 4e-06, "average": 0.99877, "min": 0.987433}, "location": {"width": 1014, "top": 1347, "height": 52, "left": 99}, "words": "并可能增多本品引起的神经病变及红细胞生成紊乱的危险性,但有报告如先用前述各药后再用本"}, {"probability": {"variance": 2e-06, "average": 0.998939, "min": 0.995111}, "location": {"width": 474, "top": 1389, "height": 44, "left": 98}, "words": "品,则毒性似较先用本品或同时用两药者为轻"}, {"probability": {"variance": 4.7e-05, "average": 0.996908, "min": 0.965382}, "location": {"width": 987, "top": 1409, "height": 55, "left": 112}, "words": "(2)由于本品可增高血尿酸的浓度,故当与别嘌醇或秋水仙碱、磺吡酮等抗痛风药合用时,要调"}, {"probability": {"variance": 2e-05, "average": 0.99847, "min": 0.971606}, "location": {"width": 1000, "top": 1443, "height": 52, "left": 103}, "words": "节上述抗痛风药的剂量以控制高尿酸血症及痛风。一般抗痛风药选用别嘌醇,因该药可阻止或逆转"}, {"probability": {"variance": 8e-06, "average": 0.99801, "min": 0.989671}, "location": {"width": 309, "top": 1493, "height": 37, "left": 99}, "words": "门冬酰胺酶引起的高尿酸血症"}, {"probability": {"variance": 2.3e-05, "average": 0.996836, "min": 0.980204}, "location": {"width": 800, "top": 1511, "height": 52, "left": 112}, "words": "(3)糖尿病患者用本品时及治疗后,均须注意调节口服降糖药或胰岛素的剂量"}], "language": -1}